Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. Paul Hartmann AG
  6. Summary
    PHH2   DE0007474041

PAUL HARTMANN AG

(PHH2)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
366(c) 367(c) 365(c) 365(c) 365(c) Last
597 35 0 467 40 Volume
0.00% +0.27% -0.54% 0.00% 0.00% Change
More quotes
Estimated financial data (e)
Sales 2019 2 194 M 2 572 M 2 572 M
Net income 2019 58,3 M 68,3 M 68,3 M
Net cash position 2019 21,4 M 25,1 M 25,1 M
P/E ratio 2019 17,2x
Yield 2019 2,48%
Sales 2020 2 440 M 2 860 M 2 860 M
Net income 2020 106 M 125 M 125 M
Net cash position 2020 169 M 198 M 198 M
P/E ratio 2020 11,9x
Yield 2020 2,25%
Capitalization 1 296 M 1 518 M 1 519 M
EV / Sales 2019 0,45x
EV / Sales 2020 0,45x
Nbr of Employees 10 622
Free-Float 17,9%
More Financials
Company
Paul Hartmann AG is a Germany-based holding company that is principally engaged in the field of medical and healthcare products. The Company operates through four segments, namely Wound Management, Incontinence Management, Infection Management and Other Group Activities. The Wound Management segment comprises wound dressings, as well as products for compression treatment, immobilization, First Aid and diagnostic... 
More about the company
All news about PAUL HARTMANN AG
08/11PAUL HARTMANN : Q2 2021 Quarterly Information
PU
08/11PAUL HARTMANN : HARTMANN's sales and earnings decline compared with previous quarters, as ..
PU
08/11Paul Hartmann AG Reports Earnings Results for the Half Year Ended June 30, 2021
CI
07/13PAUL HARTMANN : HARTMANN becomes hygiene partner of the Allianz Arena in Munich
PU
04/30PAUL HARTMANN : HARTMANN's dynamic growth in previous quarters slows noticeably in first q..
PU
03/23Paul Hartmann Ag Reports Earnings Results for the Full Year Ended December 31, 2020
CI
02/23PAUL HARTMANN : Changes in the Management Board of the HARTMANN GROUP
PU
2020PAUL HARTMANN : HARTMANN adjusts forecast for fiscal year 2020
PU
2020PAUL HARTMANN : Quarterly Information 2020 Q3
PU
2020PAUL HARTMANN : HARTMANN raises forecast due to temporary effects of coronavirus pandemic
PU
2020PAUL HARTMANN : Stefan Müller appointed as new CFO of the HARTMANN GROUP
PU
2020PALERO CAPITAL GMBH COMPLETED THE AC : Phh2),
CI
2020PALERO AGREED TO ACQUIRE SANIMED GRO : Phh2).
CI
2019PAUL HARTMANN : HARTMANN GROUP achieves sales growth of 3.7% in the first half of 2019
EQ
2019Hartmann Group Reports Earnings Results for the First Half of 2019; Provides Earnings G..
CI
More news
News in other languages on PAUL HARTMANN AG
08/11PAUL HARTMANN : Quartalsinformationen Q2/2021
08/11PAUL HARTMANN : Erwartungsgemäß rückläufige Umsatz- und Ergebnisentwicklung gegenüber Vorq..
08/11OTS : PAUL HARTMANN AG / HARTMANN: Umsatz und Ergebnis unter Druck
07/12Medizinkonzern Hartmann will im Oktober Zukunft für Standort Heidenheim klären
04/30HARTMANN : Wachstumsdynamik der letzten Quartale verlangsamt sich im ersten Quartal 2021 m..
More news
Chart PAUL HARTMANN AG
Duration : Period :
Paul Hartmann AG Technical Analysis Chart | PHH2 | DE0007474041 | MarketScreener
Technical analysis trends PAUL HARTMANN AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Managers and Directors
Britta Fuenfstueck Chairman-Management Board & CEO
Stefan MŘller Chief Financial Officer
Fritz-JŘrgen Heckmann Chairman-Supervisory Board
Bernhard Wittmann Senior Vice President-Global Operations Management
Christine Geppert Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
PAUL HARTMANN AG2.53%1 518
ABBOTT LABORATORIES13.59%220 485
MEDTRONIC PLC11.00%174 982
BECTON, DICKINSON AND COMPANY1.18%72 711
HOYA CORPORATION30.69%62 143
ALIGN TECHNOLOGY, INC.35.72%57 302